Research Roundup

Debbie Rigby rounds up the latest in research news Is it time to move away from short-acting beta-agonists in asthma management? Evidence suggests that short-acting beta-agonist (SABAs) inhalers continue to be responsible for high levels of poorly controlled asthma and even asthma deaths. Increased SABA use at the time of worsening asthma symptoms leads to